Chargement en cours...
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance
BACKGROUND: Dimethyl fumarate (DMF), a disease-modifying therapy for multiple sclerosis (MS), causes lymphopenia in a fraction of patients. The clinical significance of this is unknown. Several cases of progressive multifocal leukoencephalopathy in lymphopenic fumarate-treated patients have raised c...
Enregistré dans:
| Publié dans: | Mult Scler J Exp Transl Clin |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636217/ https://ncbi.nlm.nih.gov/pubmed/26550483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217315596994 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|